These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7560855)

  • 21. Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis.
    Del Gaudio M; Grazi GL; Principe A; Ravaioli M; Ercolani G; Cescon M; Varotti G; Gardini A; Cavallari A
    Hepatogastroenterology; 2004; 51(56):510-4. PubMed ID: 15086193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection.
    Zhong C; Wei W; Su XK; Li HD; Xu FB; Guo RP
    Hepatogastroenterology; 2012; 59(113):93-7. PubMed ID: 22251524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
    Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
    Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis.
    Cucchetti A; Vivarelli M; Piscaglia F; Nardo B; Montalti R; Grazi GL; Ravaioli M; La Barba G; Cavallari A; Bolondi L; Pinna AD
    J Hepatol; 2005 Aug; 43(2):310-6. PubMed ID: 15970351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen receptor in hepatocellular carcinoma as a prognostic factor after hepatic resection.
    Nagasue N; Chang YC; Hayashi T; Galizia G; Kohno H; Nakamura T; Yukaya H
    Ann Surg; 1989 Apr; 209(4):424-7. PubMed ID: 2539062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
    Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
    Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
    Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
    World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of risk factors and Ki-67 on rates of recurrence on patients who have undergone liver transplant for hepatocellular carcinoma.
    Aktas S; Karakayali H; Moray G; Ozdemir H; Haberal M
    Transplant Proc; 2011 Dec; 43(10):3807-12. PubMed ID: 22172851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study.
    Huang GT; Lee PH; Tsang YM; Lai MY; Yang PM; Hu RH; Chen PJ; Kao JH; Sheu JC; Lee CZ; Chen DS
    Ann Surg; 2005 Jul; 242(1):36-42. PubMed ID: 15973099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can determination of the proliferative capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma?
    Chiu JH; Wu LH; Kao HL; Chang HM; Tsay SH; Loong CC; Chau GY; Lui WY
    Hepatology; 1993 Jul; 18(1):96-102. PubMed ID: 8392030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Outcome After Resection of Huge Hepatocellular Carcinoma ≥ 10 cm: Single-Institution Experience with 471 Patients.
    Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee SG
    World J Surg; 2015 Oct; 39(10):2519-28. PubMed ID: 26126423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation.
    Kubo S; Kinoshita H; Hirohashi K; Tanaka H; Tsukamoto T; Hamba H; Shuto T; Yamamoto T; Ikebe T; Wakasa K
    Hepatogastroenterology; 1999; 46(30):3212-5. PubMed ID: 10626188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low counts of γδ T cells in peritumoral liver tissue are related to more frequent recurrence in patients with hepatocellular carcinoma after curative resection.
    Cai XY; Wang JX; Yi Y; He HW; Ni XC; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
    Asian Pac J Cancer Prev; 2014; 15(2):775-80. PubMed ID: 24568494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The state of recurrence and the role of hepatectomy in hepatocellular carcinoma.
    Hashimoto T; Nakayama S; Fukkuhara T; Okuno T; Takamine Y; Konishi Y; Tani T; Kajiwara T
    Hepatogastroenterology; 1994 Apr; 41(2):144-9. PubMed ID: 8056402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laparoscopic ablation therapies or hepatic resection in cirrhotic patients with small hepatocellular carcinoma.
    Santambrogio R; Bruno S; Kluger MD; Costa M; Salceda J; Belli A; Laurent A; Barabino M; Opocher E; Azoulay D; Cherqui D
    Dig Liver Dis; 2016 Feb; 48(2):189-96. PubMed ID: 26675381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of postoperative recurrence of hepatocellular carcinoma with radiofrequency ablation comparing with repeated surgical resection].
    Ren ZG; Gan YH; Fan J; Chen Y; Wu ZQ; Qin LX; Ge NL; Zhou J; Xia JL; Wang YH; Ye QH; Wang L; Ye SL
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1614-6. PubMed ID: 19094752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal human liver.
    Eagon PK; Francavilla A; DiLeo A; Elm MS; Gennari L; Mazzaferro V; Colella G; Van Thiel DH; Strazl TE
    Dig Dis Sci; 1991 Sep; 36(9):1303-8. PubMed ID: 1654243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers.
    Lang H; Sotiropoulos GC; Brokalaki EI; Schmitz KJ; Bertona C; Meyer G; Frilling A; Paul A; Malagó M; Broelsch CE
    J Am Coll Surg; 2007 Jul; 205(1):27-36. PubMed ID: 17617329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.